Not Medicare Enrolled
Dr. Mark Kipnes, MD
Endocrinology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kipnes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kipnes? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kipnes
Dr. Mark Kipnes is an endocrinology in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kipnes performed 6,496 Medicare services across 5,131 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kipnes received a total of $33,001 from 70 pharmaceutical and/or device companies across 1390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kipnes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 7% volume in TX$ $33,001 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,496
Medicare services
Top 7% in TX for endocrinology
5,131
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~342 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 786 | $6 | $6 |
| Office visit, established patient (30-39 min) | 663 | $77 | $209 |
| Comprehensive metabolic blood panel | 610 | $10 | $29 |
| Hemoglobin A1c test (diabetes monitoring) | 548 | $9 | $27 |
| Thyroid stimulating hormone (TSH) test | 488 | $16 | $46 |
| Free thyroxine (T4) test | 478 | $9 | $25 |
| Lipid panel (cholesterol and triglycerides) | 447 | $13 | $37 |
| Vitamin D level test | 378 | $29 | $75 |
| Phosphate level test | 337 | $5 | $13 |
| Complete blood count (CBC) with differential | 293 | $8 | $21 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 174 | $25 | $87 |
| Ferritin level test (iron stores) | 150 | $13 | $37 |
| Office visit, established patient, complex (40-54 min) | 125 | $121 | $282 |
| Glycated protein level | 115 | $16 | $41 |
| Parathyroid hormone level test | 109 | $40 | $113 |
| Creatinine test (kidney function) | 100 | $5 | $14 |
| Urine microalbumin test (kidney screening) | 99 | $6 | $15 |
| Vitamin B-12 level test | 85 | $15 | $41 |
| Office visit, established patient (20-29 min) | 59 | $57 | $142 |
| Drug injection, under skin or into muscle | 40 | $10 | $49 |
| Bone density scan (DEXA) | 34 | $37 | $78 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 34 | $27 | $79 |
| C-peptide (protein) level | 34 | $20 | $57 |
| Thyroglobulin (thyroid protein) antibody measurement | 32 | $16 | $44 |
| Sex hormone binding globulin (protein) level | 29 | $20 | $60 |
| Basic metabolic blood panel | 28 | $8 | $23 |
| Creatine kinase (cardiac enzyme) level, total | 28 | $6 | $18 |
| Kidney function blood test panel | 26 | $9 | $24 |
| Urinalysis with microscopic exam | 22 | $3 | $9 |
| Measurement of liver stiffness | 20 | $19 | $120 |
| Prolactin (milk producing hormone) level | 19 | $19 | $53 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 18 | $18 | $51 |
| Gonadotropin, luteinizing (reproductive hormone) level | 18 | $18 | $51 |
| Thyroid hormone, t3 measurement, free | 18 | $17 | $46 |
| Cortisol (hormone) measurement, total | 15 | $16 | $45 |
| Microsomal antibodies (autoantibody) measurement | 15 | $14 | $40 |
| Liver function blood test panel | 11 | $8 | $22 |
| Ldl cholesterol level | 11 | $10 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,001
Total received (2018-2024)
Avg $4,714/year across 7 years
Top 18% in TX for endocrinology
70
Companies
1,390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,074 (76.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,199 (18.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,728 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,621
2023$5,763
2022$3,603
2021$3,903
2020$4,523
2019$8,133
2018$4,455
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$4,064
Novo Nordisk Inc
$3,784
AstraZeneca Pharmaceuticals LP
$2,198
Tandem Diabetes Care, Inc.
$1,802
Lilly USA, LLC
$1,545
Radius Health, Inc.
$1,426
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,282
Boehringer Ingelheim International GmbH
$1,244
Amgen Inc.
$1,224
SANOFI-AVENTIS U.S. LLC
$940
Mannkind Corporation
$898
Medtronic, Inc.
$826
Abbott Laboratories
$813
Amarin Pharma Inc.
$785
Ascensia Diabetes Care Us Inc.
$763
Xeris Pharmaceuticals, Inc.
$731
MannKind Corporation
$723
PFIZER INC.
$633
Antares Pharma, Inc.
$590
Medtronic MiniMed, Inc.
$559
Corcept Therapeutics
$472
Valeritas, Inc.
$454
Novartis Pharmaceuticals Corporation
$401
RECORDATI_RARE_DISEASES_INC.
$386
AbbVie, Inc.
$350
AbbVie Inc.
$346
ABBVIE INC.
$315
Merck Sharp & Dohme Corporation
$313
Zealand Pharma US, Inc.
$299
Esperion Therapeutics, Inc.
$273
Dexcom, Inc.
$214
Becton, Dickinson and Company
$204
Janssen Pharmaceuticals, Inc
$177
CeQur Corporation
$176
BETA BIONICS, INC.
$162
Bayer Healthcare Pharmaceuticals Inc.
$139
Ultragenyx Pharmaceutical Inc.
$137
Insulet Corporation
$123
Shire North American Group Inc
$100
Senseonics, Incorporated
$96
Nalpropion Pharmaceuticals LLC
$89
Ipsen Biopharmaceuticals, Inc
$71
Merck Sharp & Dohme LLC
$68
Bayer HealthCare Pharmaceuticals Inc.
$61
EUSA Pharma (US) LLC
$58
OPKO Pharmaceuticals, LLC
$56
DEXCOM, INC.
$45
Orexigen Therapeutics, Inc.
$44
Currax Pharmaceuticals LLC
$43
Tolmar, Inc.
$42
IBSA Pharma Inc.
$38
Strongbridge US INC.
$36
Nalpropion Pharmaceuticals, Inc.
$29
LIFESCAN, INC.
$29
Companion Medical, Inc.
$29
Kyowa Kirin, Inc.
$25
Organogenesis Inc.
$24
Roche Diabetes Care, Inc.
$24
Eisai Inc.
$24
Neurocrine Biosciences, Inc.
$23
LifeScan, Inc.
$22
Almatica Pharma LLC
$22
Supernus Pharmaceuticals, Inc.
$21
Amryt Pharma Holdings Ltd
$19
Horizon Therapeutics plc
$17
Nevro Corp.
$16
GRT US Holding, Inc.
$15
Acerus Pharmaceuticals Corporation
$14
Intuity Medical Inc
$14
AKRIMAX PHARMACEUTICALS, LLC
$12
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · CHANTIX · CONTRAVE · CREON · Cables · CeQur Simplicity · Creon · Crysvita · Cryvista · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · Dojolvi · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GENOTROPIN · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kits and Accessories · Korlym · LANTUS · LEQVIO · LINZESS · LYRICA · Levemir · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · Otezla · Otrexup · Ozempic · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Proclaim Family of SCS IPGs · Prolia · Puraply · Qutenza · RAYALDEE · RECORLEV · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Software · Sogroya · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TOVIAZ · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VANTA ADAPTIVESTIM · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZAVZPRET · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $508 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
62
Per 100K population
3.0
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kipnes is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (low-engagement, top 18%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kipnes experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Kipnes performed 786 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kipnes receive payments from pharmaceutical companies?
Yes. Dr. Kipnes received a total of $33,001 from 70 companies across 1,390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kipnes's costs compare to other endocrinologys in San Antonio?
Dr. Kipnes's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kipnes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in San Antonio
Browse endocrinologys in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in TX
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in TX
Which TX endocrinologys receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology